E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions-Reference-Cited by-同舟云学术

E-pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions

Published:2013-09 Issue: Volume:76 Page:69-77
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Neubert Antje¹,Dormann Harald²,Prokosch Hans-Ulrich³,Bürkle Thomas³,Rascher Wolfgang¹,Sojer Reinhold⁴,Brune Kay⁵,Criegee-Rieck Manfred³

Affiliation:

1. Department of Paediatric and Adolescent Medicine; University Hospital Erlangen; Erlangen

2. Emergency Department; Hospital Fuerth; Fuerth

3. Chair of Medical Informatics; University Erlangen-Nuremberg; Erlangen; Germany

4. BlueCare AG; Winterthur; Switzerland

5. Doerenkamp-Professorship for Innovations in Animal and Consumer Protection; Institute of Experimental and Clinical Pharmacology and Toxicology; University Erlangen-Nuremberg; Erlangen; Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12127/fullpdf

Reference42 articles.

1. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies;Lazarou;JAMA,1998

2. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group;Bates;JAMA,1997

3. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality;Classen;JAMA,1997

4. The thalidomide tragedy in Germany: the end of a historic medicolegal trial;Curran;N Engl J Med,1971

5. Innovations for the future of pharmacovigilance;Almenoff;Drug Saf,2007

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patients with Irritable Bowel Syndrome After a New Coronavirus Infection (VESNA);Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-12-01

2. A retrospective case-control study on menstrual cycle changes following COVID-19 vaccination and disease;iScience;2023-04

3. Adverse drug reactions (ADRs) case studies: Moderate ADRs;Clinical Case Studies on Medication Safety;2023

4. Utility of a Laboratory Alert System for Detecting Adverse Drug Reactions in Hospitalised Patients: Hyponatremia and Rhabdomyolysis;Frontiers in Pharmacology;2022-07-06

5. Safety of Quinolones in Children: A Systematic Review and Meta-Analysis;Pediatric Drugs;2022-06-30